Cheng Andrew Insider Profile

Cheng Andrew, Director at Arbutus Biopharma, holds ― shares in Arbutus Biopharma (Ticker: ABUS), holds 461.00K shares in Akero Therapeutics (Ticker: AKRO), holds 17.49K shares in Vera Therapeutics (Ticker: VERA). Most recently, Cheng Andrew ― shares of Arbutus Biopharma on ― for an estimated value of ―.
Cheng Andrew

Cheng Andrew
Arbutus Biopharma (ABUS)

Ranked #20,191 out of 105,137 Corporate Insiders

Profitable Transactions

4 out of 7 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Cheng Andrew's holdings

Insider Roles

Akero Therapeutics
President & CEO, Director
Vera Therapeutics
Arbutus Biopharma
Roles that Cheng Andrew holds in companies

Most Profitable Insider Trade

Akero Therapeutics
Rating:Informative Buy
Date:Jan 04, 2022 - Jan 04, 2023
The most profitable trade made by Cheng Andrew

Cheng Andrew's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arbutus Biopharma
Akero Therapeutics
Sep 25, 2023
President & CEO, Director
Uninformative Sell
Vera Therapeutics
May 18, 2021
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Cheng Andrew's performance on stock

Cheng Andrew insider profile FAQ

What is the percentage of profitable transactions made by Cheng Andrew?
The percentage of profitable transactions made by Cheng Andrew is 57%.
    What is the average return per transaction made by Cheng Andrew?
    The average return per transaction made by Cheng Andrew is 14.10%.
      What stocks does Cheng Andrew hold?
      Cheng Andrew holds: ABUS, AKRO, VERA stocks.
        What was Cheng Andrew’s latest transaction?
        Cheng Andrew latest transaction was an Uninformative Buy of ―.
          What was Cheng Andrew's most profitable transaction?
          Cheng Andrew’s most profitable transaction was an Informative Buy of AKRO stock on January 4, 2022. The return on the trade was 114.50%.
            What is Cheng Andrew's role in Arbutus Biopharma?
            Cheng Andrew's role in Arbutus Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.